hotspot -WSS

hotspot

author：focus 2025-09-30 23:20:36 - browse：962

A pharmacy technician prepares prescriptions for packaging and shipping after being filled. health policy coverage from STAT — George Frey/Getty Images

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how.

The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

The White House also has a new task force that is supposed to put together recommendations for fighting drug shortages, one it formed early this year in response to news of the worsening drug shortage crisis as the country began running out of an increasing number of chemotherapies. It has met with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm solutions, but it’s not clear what it has in mind or when it will make those recommendations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： The FDA weighs the risks of candy

hotspot

WSS

The pink breast cancer awareness ribbon needs a redesign

Medicare drug price negotiation hasn't dried up venture capital

Traditional Chinese medicine benefits explored in new JAMA study

Maker of FluMist seeks to allow at

Medicare Advantage beneficiaries sue Humana over algorithm use

Why health care costs have stayed mostly flat since 2010

focus

hotspot

hotspot

Apple is now the first public company to be valued at $3 trillion

Cassava reveals details — and problems — with Alzheimer's study

Heart attack and stroke risk calculators need revising

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Drug repurposing or repositioning? The language matters

Paying for Covid pills will soon shift to insurers

Hollywood unions extend contract negotiations for actors

What STAT readers think about the FDA and patient advocacy

Hepatitis C has a cure — but many Americans still lack access to it

HCA sued by state AG for quality issues at Mission Health

explore

Albert Bourla of Pfizer: worst biopharma CEO of 2023

The pink breast cancer awareness ribbon needs a redesign

Emergency medicine has repudiated 'excited delirium.' Now what?

Medicare drug price negotiation hasn't dried up venture capital

Grail spinoff by Illumina should end disastrous merger attempt

Christmas in the PICU brings some surprising joy

explore

hotspot

hotspot

hotspot